VanEck Pharmaceutical ETF (NASDAQ:PPH) Sets New 12-Month High – What’s Next?

VanEck Pharmaceutical ETF (NASDAQ:PPH)’s stock price hit a new 52-week high on Monday . The stock traded as high as $111.47 and last traded at $110.4580, with a volume of 5325 shares trading hands. The stock had previously closed at $110.45.

VanEck Pharmaceutical ETF Price Performance

The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of 20.21 and a beta of 0.54. The business’s 50 day moving average price is $103.98 and its 200-day moving average price is $95.66.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 31st. Investors of record on Monday, December 29th were issued a dividend of $0.3106 per share. The ex-dividend date of this dividend was Monday, December 29th. This represents a $1.24 dividend on an annualized basis and a yield of 1.1%.

Institutional Trading of VanEck Pharmaceutical ETF

A number of institutional investors have recently bought and sold shares of the company. CWM LLC raised its stake in VanEck Pharmaceutical ETF by 36.3% in the 4th quarter. CWM LLC now owns 511 shares of the company’s stock valued at $53,000 after purchasing an additional 136 shares during the last quarter. IFP Advisors Inc raised its position in shares of VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 153 shares during the last quarter. Orion Porfolio Solutions LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 0.5% during the third quarter. Orion Porfolio Solutions LLC now owns 33,693 shares of the company’s stock valued at $3,044,000 after buying an additional 180 shares during the period. Cibc World Market Inc. lifted its stake in shares of VanEck Pharmaceutical ETF by 5.1% during the third quarter. Cibc World Market Inc. now owns 4,282 shares of the company’s stock valued at $387,000 after buying an additional 207 shares during the period. Finally, Farther Finance Advisors LLC boosted its position in VanEck Pharmaceutical ETF by 64.7% during the fourth quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after acquiring an additional 282 shares during the last quarter.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.